From: Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility
Median (range) or N (%)
In-hospital death
0 (0)
Established oral feeding at discharge
8 (89)
Mechanical ventilation at discharge
1 (11)
Normal brain MRI findings
7 (78)
Hospital stay, days
18 (16, 81)